Dexamethasone Sodium Phosphate · Regulatory label update
U.S. Food and Drug Administration · July 17, 2026
An action by a regulator. Authoritative on labelling and availability.
This is an FDA supplemental approval of dexamethasone sodium phosphate labeling, issued 17 July 2026 by Fresenius Kabi USA for the injectable 10 mg/mL formulation. The record documents regulatory action only and does not contain clinical trial results, efficacy data, or comparative evidence.
Regulatory label update.
Supplemental labeling approval for dexamethasone sodium phosphate injectable, 10 mg/mL, issued 2026-07-17
Record does not contain clinical trial results, safety data, or efficacy evidence.
This regulatory action confirms FDA acceptance of revised labeling for dexamethasone sodium phosphate injectable. Clinicians should refer to the updated prescribing information for current indications, dosing, and safety information, but this record does not itself report clinical trial outcomes or evidence of efficacy.
FDA supplemental approval of dexamethasone sodium phosphate labeling; describes regulatory action only, not clinical evidence or efficacy.
Quoted from the source exactly as published.
This regulatory action confirms FDA acceptance of revised labeling for dexamethasone sodium phosphate injectable. Clinicians should refer to the updated prescribing information for current indications, dosing, and safety information, but this record does not itself report clinical trial outcomes or evidence of efficacy.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Drugs@FDA record for application ANDA209192. This is a regulatory action record, not a clinical study. Brand name: DEXAMETHASONE SODIUM PHOSPHATE. Active ingredient: DEXAMETHASONE SODIUM PHOSPHATE. Sponsor: FRESENIUS KABI USA. Submission type: SUPPL (supplement). Submission class: Labeling. Approval status date: 2026-07-17. Products: DEXAMETHASONE SODIUM PHOSPHATE, INJECTABLE, INJECTION, DEXAMETHASONE SODIUM PHOSPHATE EQ 10MG PHOSPHATE/ML.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.